Recruiting NA Sensorineural Hearing Loss

New treatment option for Sensorineural Hearing Loss

Official title Perceptual Adaptation Following Cochlear Implantation (Aim 3a)

ClinicalTrials.gov ID: NCT07039435

What this study is testing

What it's testing
The goal of this study is to study the adaptation process in newly implanted Single-Sided Deaf Cochlear Implant (SSD-CI) users. Subjects will use four frequency maps for the first month after CI activation.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Age 18 or older
  • No known anatomical abnormalities in either ear
  • English speaking
  • Intends to receive a cochlear implant in one ear (or has already received it but it has not been activated).
  • Normal hearing (or minimal hearing loss) in the contralateral ear

You likely can't join if

  • Under age 18
  • Documented anatomical abnormality of the implanted ear
  • Non-English speaking
  • Greater than minimal hearing loss in the contralateral ear.

The study team makes the final eligibility decision.

Where it's taking place

  • New York, New York, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.